CFCII's Director provides us with an overview of the services offered to French and Italian companies by the Chamber, as well as her perceptions about…

The president of HAS sheds light on the seemingly complex French healthcare system, explains HAS’ role within that context and provides an honest…

Brian Gladsden was appointed president of Novartis Korea in January 2014. He relates his previous experience to the market situation in Korea and…

The executive director of the board bringing together multinational and local drug manufacturers talks about the chamber’s goal to position the…

Carlos Chiale, National Administrator of ANMAT, discusses the agency’s latest strategy implementation and its pioneering work in the area of…